imidocarb has been researched along with Malaria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Daim, MM; Alkhoudary, MS; Alsharif, KF; El-Sayed, SAE; Igarashi, I; Rizk, MA | 1 |
| Baghdadi, HB; El-Sayed, SAE; Eltaysh, R; Igarashi, I; Rizk, MA | 1 |
2 other study(ies) available for imidocarb and Malaria
| Article | Year |
|---|---|
Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
Topics: Animals; Antiprotozoal Agents; Atovaquone; Babesia; Babesiosis; Blood-Borne Pathogens; Diminazene; Humans; Imidocarb; Malaria; Plants, Medicinal | 2021 |
Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis.
Topics: Animals; Atovaquone; Babesia microti; Babesiosis; Clofazimine; Cysteine Proteases; Drug Repositioning; Imidocarb; Malaria; Mice; Theileria | 2022 |